Full article on MedExpo e-magazine: http://www.medicalexpo.com/emag/4/files/14.html
Thank your for attending the HealthTech Conference on October 14th & 15th. We sold out with more than 460 attendees and 47 exhibitors. Check the conference pictures!
We would welcome your participation in a web video discussion of Lessons Learned at the HealthTech Conference. Please join our FREE Zoom webinar on Thursday, October 30.
Please spread the word:
Please check our blog where we announce Vitreos Health as the winner of our venture panel for Most Promising Healthtech Company of 2014 as well as Accel Diagnostics who won the audience vote for the People's Choice award.
October 21, 2014 - The HealthTech Conference once again gathered around 500 of the brightest minds in Healthcare and Technology last week at the two-day event in San Mateo, CA. Hosted by Anne DeGheest and Don Ross of HealthTech Capital, the conference explored how to build sustainable HealthTech Businesses by bringing together the best minds from the existing healthcare stakeholders with investors and creative entrepreneurs. The yearly gathering convened HealthTech leaders to discuss the greatest industry pain-points and define best approaches to change healthcare delivery in the changing payment system and realignment of risk between employers, payers, providers, physicians and ultimately the consumers!
One of the major opportunities discussed by panelists was the need for increased collaboration between hospitals, established industry players and entrepreneurs to improve healthcare delivery models through technology innovation and partnerships. In line with this theme, HealthTech Conference hosted a Start-up Venture Competition intended to identify innovative companies that leverage technologies to change healthcare delivery, decrease cost and empower patients. Live at the event, three start-up founder finalists, Vitreous Health, Frame Health and iHuman Patients presented their companies and received feedback from the Venture Panel, including: Joel Krikston of Merck Global Health Innovation Fund, Wende Hutton of Canaan Partners, Casper de Clercq of Norwest Venture Partners and Jonathan Root of U.S. Venture Partners.